PWMG
DFTX icon

Private Wealth Management Group’s Definium Therapeutics DFTX Stock Holding History

Private Wealth Management Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-450
Closed -$8.5K – 1495
2026
Q1 		$8.5K Buy
+450
New +$7.64K ﹤0.01% 577

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Private Wealth Management Group's DFTX Position: Q2 2026 in Review

Private Wealth Management Group sold out of Definium Therapeutics (DFTX) in Q2 2026, closing a stake of 450 shares — an estimated $8.5K sold.

Private Wealth Management Group first reported a position in DFTX in Q1 2026 and held it in 1 quarter. The position peaked at $8.5K in Q1 2026. 363 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Private Wealth Management Group reported no remaining Definium Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Private Wealth Management Group sold 450 Definium Therapeutics shares in Q2 2026, an estimated $8.5K.
  • Private Wealth Management Group first reported a position in Definium Therapeutics in Q1 2026 and held it in 1 quarter.
  • Private Wealth Management Group's Definium Therapeutics position peaked at $8.5K in Q1 2026.
  • 363 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.